AB006. Impact and approach for drug shortages on patient care: a case report of finasteride unavailability for benign prostatic hyperplasia in a public hospital
Acknowledgments
Funding: None.
Footnote
Conflicts of Interest: The author has completed the ICMJE uniform disclosure form (available at https://jphe.amegroups.com/article/view/10.21037/jphe-2023-apru-ab006/coif). The author has no conflicts of interest to declare.
Ethical Statement: The author is accountable for all aspects of the work in ensuring that questions related to the accuracy or integrity of any part of the work are appropriately investigated and resolved. All procedures performed this study were in accordance with the ethical standards of the institutional and national research committees and with the Helsinki Declaration (as revised in 2013). Written informed consent for publication of this abstract was not obtained from the patient or the relatives after all possible attempts were made. The abstract has been sufficiently anonymized to cause no harm to the patient or his family.
Open Access Statement: This is an Open Access article distributed in accordance with the Creative Commons Attribution-NonCommercial-NoDerivs 4.0 International License (CC BY-NC-ND 4.0), which permits the noncommercial replication and distribution of the article with the strict proviso that no changes or edits are made and the original work is properly cited (including links to both the formal publication through the relevant DOI and the license). See: https://creativecommons.org/licenses/by-nc-nd/4.0/.
Cite this abstract as: Cabrera Maya AA. AB006. Impact and approach for drug shortages on patient care: a case report of finasteride unavailability for benign prostatic hyperplasia in a public hospital. J Public Health Emerg 2024;8:AB006.